CrushSCI.com
Journal Selection & Manuscript Polishing Services
ALIMENTARY PHARMACOLOGY & THERAPEUTICS journal cover Medicine
Back to journal directory

Review Cycle Records

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Wiley SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
72.5Average days
30.5Median days
2Fastest days
312Longest days
6092025 publications

Paper Review Records

All Paper Review Records

18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

87 days

Clinical Trial: Effectiveness and Safety of a Novel Anal Insert Device for Treatment of Faecal Incontinence

AuthorsAdil E. Bharucha; Ramesh Lamichhane; Joel G. Fletcher; Nicholas R. Oblizajek; Misha Gautam; Kent R. Bailey; Lawrence A. Szarka

Affiliations1. Division of Gastroenterology and Hepatology (Bharucha, Oblizajek, and Szarka), Department of Radiology (Fletcher), and Division of Clinical Trials and Biostatistics (Bailey) Mayo Clinic, Mayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science Rochester Minnesota USA

Source PDF DOI Publisher page
4 days

Letter: Personalised FODMAP Modulation in IBS —Towards Less Restrictive Dietary Care

AuthorsVarol Tunali; Serena Porcari; Antonio Gasbarrini; Gianluca Ianiro

Affiliations1. Department of Translational Medicine and Surgery Università Cattolica del Sacro Cuore Rome Italy; 2. Department of Medical and Surgical Sciences, UOC CEMAD Centro Malattie Dell'apparato Digerente, Medicina Interna e Gastroenterologia Fondazione Policlinico Universitario Gemelli IRCCS Rome Italy; 3. Faculty of Medicine Izmir University of Economics Izmir Türkiye

Source PDF DOI Publisher page
104 days

Meta‐Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorders

AuthorsDmitrii Kulin; Gerald Holtmann; Thomas Fairlie; Kyle Staller; Samuel Nurko; Laurie Keefer; Douglas A. Drossman; Michael P. Jones; Qasim Aziz; Ayesha Shah

Affiliations1. Faculty of Medicine The University of Queensland Brisbane Queensland Australia; 2. Translational Research Institute Brisbane Queensland Australia; 3. Department of Gastroenterology & Hepatology Princess Alexandra Hospital Brisbane Queensland Australia; 4. Centre for Neurointestinal Health, Division of Gastroenterology Massachusetts General Hospital Boston Massachusetts USA; 5. Harvard Medical School Boston Massachusetts USA; 6. Centre for Motility and Functional Gastrointestinal Disorders Boston Children's Hospital Boston Massachusetts USA; 7. Department of Pediatrics Harvard Medical School Boston Massachusetts USA; 8. Division of Gastroenterology Icahn School of Medicine at Mount Sinai New York City New York USA; 9. Division of Gastroenterology University of N.C. and Drossman Gastroenterology Chapel Hill North Carolina USA; 10. School of Psychological Sciences Macquarie University North Ryde Australia; 11. Wingate Institute of Neurogastroenterology, Queen Mary University of London London UK

Source PDF DOI Publisher page
131 days

Meta‐Analysis: Redefining Liver Disease Risk in Heterozygous Alpha‐1 Antitrypsin Deficiency

AuthorsAdam M. Syanda; Dimitra Georgantaki; Riona T. T. Linn; Amara Agbai; Hassan Tahir; Manako Sakai; Richard Thompson; Mariam Molokhia; S. Tamir Rashid

Affiliations1. Department of Metabolism, Digestion and Reproduction, Faculty of Medicine Imperial College London London UK; 2. Department of Population Health Sciences School of Life Course and Population Sciences, King's College London London UK; 3. Faculty of Medicine Imperial College London London UK; 4. Institute of Liver Studies King's College London London UK

Source PDF DOI Publisher page
6 days

Letter: Nuanced Interpretation of Faecal Calprotectin During Maintenance of Ulcerative Colitis Treatment: Sweet Spots and Pitfalls

AuthorsAngela Zhu; Jonathan P. Segal

Affiliations1. Department of Gastroenterology and Hepatology The Royal Melbourne Hospital Melbourne Victoria Australia; 2. Department of Medicine University of Melbourne Melbourne Victoria Australia

Source PDF DOI Publisher page
63 days

Clinical Trial: Lemborexant Efficacy and Safety in Liver Cirrhosis—Randomized, Double‐Blind, Crossover Clinical Trial

AuthorsRino Alvani Gani; Pitt Akbar; Irsan Hasan; Andri Sanityoso Sulaiman; Cosmas Rinaldi Adithya Lesmana; Juferdy Kurniawan; Sarah Melissa Panjaitan; Valerie Josephine Dirjayanto

Affiliations1. Hepatobiliary Division, Internal Medicine Department Dr Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia Jakarta Indonesia

Source PDF DOI Publisher page
5 days

Letter: Interpretation of Cognitive and Clinical Outcomes in the Randomised Trial of Rifaximin for Covert Hepatic Encephalopathy

AuthorsGlen Saward; Sumaya Al‐Ukaidey

Affiliations1. Department of Gastroenterology Barwon Health Geelong Australia

Source PDF DOI Publisher page
11 days

Letter: HBsAg Loss After COVID‐19 Vaccination: Implications for HBV Screening, Immunity Monitoring, and Health Worker Protection in LMICs. Authors' Reply

AuthorsJonggi Choi; Raymond T. Chung

Affiliations1. Department of Gastroenterology, Liver Center Asan Medical Center, University of Ulsan College of Medicine Seoul Republic of Korea; 2. Liver Center, Gastroenterology Division Massachusetts General Hospital Boston Massachusetts USA; 3. Department of Medicine Massachusetts General Hospital Boston Massachusetts USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.